MENU

Biologics weigh on group plans

By Alain Thériault | Oct. 20, 2022, 10:48 a.m.

Photo: Freepik | senivpetro

Biologics are putting a strain on private group plans by treating orphan diseases, as well as common diseases, at high cost.

This article is reserved to PRO Level subscribers

Discover the PRO Level
Advertisement
Related topics …
AFL